English
简体中文
Total: £ 56.28
Published Date: 2025-10-15 | Pages: 125 | Tables: 121 | Medical Care
The global Third-party Pathology Diagnosis Center market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
A third-party pathology diagnosis center is an independent legal entity that provides pathology diagnostic services and issues formal pathology reports. These centers are distinct from in-house pathology departments within medical institutions and serve a variety of healthcare providers, including hospitals and clinics. They are responsible for analyzing and diagnosing pathology samples and assume the corresponding legal responsibilities. By offering high-quality diagnostic services, these centers assist medical institutions in making accurate diagnostic and treatment decisions.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Third-party Pathology Diagnosis Center leading manufacturers including Unilabs, Quest Diagnostics, Sonic Healthcare, LabCorp, SYNLAB, HISTO, Fen Lan Medical, Akmpath, etc., dominate supply; the top five capture approximately % of global revenue, with Unilabs leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Third-party Pathology Diagnosis Center market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Unilabs
Quest Diagnostics
Sonic Healthcare
LabCorp
SYNLAB
HISTO
Fen Lan Medical
Akmpath
Segment by Type
Third-Party Medical Testing Laboratory
Independent Third-Party Pathology Diagnosis Center
Segment by Application
Hospital
Clinic
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Third-party Pathology Diagnosis Center study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Third-party Pathology Diagnosis Center: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Third-party Pathology Diagnosis Center Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Third-Party Medical Testing Laboratory
1.2.3 Independent Third-Party Pathology Diagnosis Center
1.3 Market Segmentation by Application
1.3.1 Global Third-party Pathology Diagnosis Center Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Third-party Pathology Diagnosis Center Revenue Estimates and Forecasts 2020-2031
2.2 Global Third-party Pathology Diagnosis Center Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Third-party Pathology Diagnosis Center Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Third-party Pathology Diagnosis Center Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Third-Party Medical Testing Laboratory Market Size by Players
3.3.2 Independent Third-Party Pathology Diagnosis Center Market Size by Players
3.4 Global Third-party Pathology Diagnosis Center Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Third-party Pathology Diagnosis Center Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Third-party Pathology Diagnosis Center Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Third-party Pathology Diagnosis Center Market Size by Type (2020-2031)
6.4 North America Third-party Pathology Diagnosis Center Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Third-party Pathology Diagnosis Center Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Third-party Pathology Diagnosis Center Market Size by Type (2020-2031)
7.4 Europe Third-party Pathology Diagnosis Center Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Third-party Pathology Diagnosis Center Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Third-party Pathology Diagnosis Center Market Size by Type (2020-2031)
8.4 Asia-Pacific Third-party Pathology Diagnosis Center Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Third-party Pathology Diagnosis Center Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Third-party Pathology Diagnosis Center Market Size by Type (2020-2031)
9.4 Central and South America Third-party Pathology Diagnosis Center Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Third-party Pathology Diagnosis Center Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Third-party Pathology Diagnosis Center Market Size by Type (2020-2031)
10.4 Middle East and Africa Third-party Pathology Diagnosis Center Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Third-party Pathology Diagnosis Center Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Unilabs
11.1.1 Unilabs Corporation Information
11.1.2 Unilabs Business Overview
11.1.3 Unilabs Third-party Pathology Diagnosis Center Product Features and Attributes
11.1.4 Unilabs Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.1.5 Unilabs Third-party Pathology Diagnosis Center Revenue by Product in 2024
11.1.6 Unilabs Third-party Pathology Diagnosis Center Revenue by Application in 2024
11.1.7 Unilabs Third-party Pathology Diagnosis Center Revenue by Geographic Area in 2024
11.1.8 Unilabs Third-party Pathology Diagnosis Center SWOT Analysis
11.1.9 Unilabs Recent Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Corporation Information
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Third-party Pathology Diagnosis Center Product Features and Attributes
11.2.4 Quest Diagnostics Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.2.5 Quest Diagnostics Third-party Pathology Diagnosis Center Revenue by Product in 2024
11.2.6 Quest Diagnostics Third-party Pathology Diagnosis Center Revenue by Application in 2024
11.2.7 Quest Diagnostics Third-party Pathology Diagnosis Center Revenue by Geographic Area in 2024
11.2.8 Quest Diagnostics Third-party Pathology Diagnosis Center SWOT Analysis
11.2.9 Quest Diagnostics Recent Developments
11.3 Sonic Healthcare
11.3.1 Sonic Healthcare Corporation Information
11.3.2 Sonic Healthcare Business Overview
11.3.3 Sonic Healthcare Third-party Pathology Diagnosis Center Product Features and Attributes
11.3.4 Sonic Healthcare Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.3.5 Sonic Healthcare Third-party Pathology Diagnosis Center Revenue by Product in 2024
11.3.6 Sonic Healthcare Third-party Pathology Diagnosis Center Revenue by Application in 2024
11.3.7 Sonic Healthcare Third-party Pathology Diagnosis Center Revenue by Geographic Area in 2024
11.3.8 Sonic Healthcare Third-party Pathology Diagnosis Center SWOT Analysis
11.3.9 Sonic Healthcare Recent Developments
11.4 LabCorp
11.4.1 LabCorp Corporation Information
11.4.2 LabCorp Business Overview
11.4.3 LabCorp Third-party Pathology Diagnosis Center Product Features and Attributes
11.4.4 LabCorp Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.4.5 LabCorp Third-party Pathology Diagnosis Center Revenue by Product in 2024
11.4.6 LabCorp Third-party Pathology Diagnosis Center Revenue by Application in 2024
11.4.7 LabCorp Third-party Pathology Diagnosis Center Revenue by Geographic Area in 2024
11.4.8 LabCorp Third-party Pathology Diagnosis Center SWOT Analysis
11.4.9 LabCorp Recent Developments
11.5 SYNLAB
11.5.1 SYNLAB Corporation Information
11.5.2 SYNLAB Business Overview
11.5.3 SYNLAB Third-party Pathology Diagnosis Center Product Features and Attributes
11.5.4 SYNLAB Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.5.5 SYNLAB Third-party Pathology Diagnosis Center Revenue by Product in 2024
11.5.6 SYNLAB Third-party Pathology Diagnosis Center Revenue by Application in 2024
11.5.7 SYNLAB Third-party Pathology Diagnosis Center Revenue by Geographic Area in 2024
11.5.8 SYNLAB Third-party Pathology Diagnosis Center SWOT Analysis
11.5.9 SYNLAB Recent Developments
11.6 HISTO
11.6.1 HISTO Corporation Information
11.6.2 HISTO Business Overview
11.6.3 HISTO Third-party Pathology Diagnosis Center Product Features and Attributes
11.6.4 HISTO Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.6.5 HISTO Recent Developments
11.7 Fen Lan Medical
11.7.1 Fen Lan Medical Corporation Information
11.7.2 Fen Lan Medical Business Overview
11.7.3 Fen Lan Medical Third-party Pathology Diagnosis Center Product Features and Attributes
11.7.4 Fen Lan Medical Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.7.5 Fen Lan Medical Recent Developments
11.8 Akmpath
11.8.1 Akmpath Corporation Information
11.8.2 Akmpath Business Overview
11.8.3 Akmpath Third-party Pathology Diagnosis Center Product Features and Attributes
11.8.4 Akmpath Third-party Pathology Diagnosis Center Revenue and Gross Margin (2020-2025)
11.8.5 Akmpath Recent Developments
12 Third-party Pathology Diagnosis CenterIndustry Chain Analysis
12.1 Third-party Pathology Diagnosis Center Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Third-party Pathology Diagnosis Center Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Third-party Pathology Diagnosis Center Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Third-party Pathology Diagnosis Center Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Third-party Pathology Diagnosis Center Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Third-party Pathology Diagnosis Center Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Third-party Pathology Diagnosis Center Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Third-party Pathology Diagnosis Center Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Third-party Pathology Diagnosis Center Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Third-party Pathology Diagnosis Center by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Pathology Diagnosis Center as of 2024)
Table 11. Global Third-party Pathology Diagnosis Center Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Third-party Pathology Diagnosis Center Companies Headquarters
Table 13. Global Third-party Pathology Diagnosis Center Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Third-party Pathology Diagnosis Center Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Third-party Pathology Diagnosis Center Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Third-party Pathology Diagnosis Center Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Third-party Pathology Diagnosis Center Revenue by Application (2026-2031) & (US$ Million)
Table 21. Third-party Pathology Diagnosis Center High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Third-party Pathology Diagnosis Center Growth Accelerators and Market Barriers
Table 25. North America Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Third-party Pathology Diagnosis Center Growth Accelerators and Market Barriers
Table 27. Europe Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Third-party Pathology Diagnosis Center Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Third-party Pathology Diagnosis Center Investment Opportunities and Key Challenges
Table 31. Central and South America Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Third-party Pathology Diagnosis Center Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Third-party Pathology Diagnosis Center Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Unilabs Corporation Information
Table 35. Unilabs Description and Major Businesses
Table 36. Unilabs Product Features and Attributes
Table 37. Unilabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Unilabs Revenue Proportion by Product in 2024
Table 39. Unilabs Revenue Proportion by Application in 2024
Table 40. Unilabs Revenue Proportion by Geographic Area in 2024
Table 41. Unilabs Third-party Pathology Diagnosis Center SWOT Analysis
Table 42. Unilabs Recent Developments
Table 43. Quest Diagnostics Corporation Information
Table 44. Quest Diagnostics Description and Major Businesses
Table 45. Quest Diagnostics Product Features and Attributes
Table 46. Quest Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Quest Diagnostics Revenue Proportion by Product in 2024
Table 48. Quest Diagnostics Revenue Proportion by Application in 2024
Table 49. Quest Diagnostics Revenue Proportion by Geographic Area in 2024
Table 50. Quest Diagnostics Third-party Pathology Diagnosis Center SWOT Analysis
Table 51. Quest Diagnostics Recent Developments
Table 52. Sonic Healthcare Corporation Information
Table 53. Sonic Healthcare Description and Major Businesses
Table 54. Sonic Healthcare Product Features and Attributes
Table 55. Sonic Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Sonic Healthcare Revenue Proportion by Product in 2024
Table 57. Sonic Healthcare Revenue Proportion by Application in 2024
Table 58. Sonic Healthcare Revenue Proportion by Geographic Area in 2024
Table 59. Sonic Healthcare Third-party Pathology Diagnosis Center SWOT Analysis
Table 60. Sonic Healthcare Recent Developments
Table 61. LabCorp Corporation Information
Table 62. LabCorp Description and Major Businesses
Table 63. LabCorp Product Features and Attributes
Table 64. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. LabCorp Revenue Proportion by Product in 2024
Table 66. LabCorp Revenue Proportion by Application in 2024
Table 67. LabCorp Revenue Proportion by Geographic Area in 2024
Table 68. LabCorp Third-party Pathology Diagnosis Center SWOT Analysis
Table 69. LabCorp Recent Developments
Table 70. SYNLAB Corporation Information
Table 71. SYNLAB Description and Major Businesses
Table 72. SYNLAB Product Features and Attributes
Table 73. SYNLAB Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. SYNLAB Revenue Proportion by Product in 2024
Table 75. SYNLAB Revenue Proportion by Application in 2024
Table 76. SYNLAB Revenue Proportion by Geographic Area in 2024
Table 77. SYNLAB Third-party Pathology Diagnosis Center SWOT Analysis
Table 78. SYNLAB Recent Developments
Table 79. HISTO Corporation Information
Table 80. HISTO Description and Major Businesses
Table 81. HISTO Product Features and Attributes
Table 82. HISTO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. HISTO Recent Developments
Table 84. Fen Lan Medical Corporation Information
Table 85. Fen Lan Medical Description and Major Businesses
Table 86. Fen Lan Medical Product Features and Attributes
Table 87. Fen Lan Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Fen Lan Medical Recent Developments
Table 89. Akmpath Corporation Information
Table 90. Akmpath Description and Major Businesses
Table 91. Akmpath Product Features and Attributes
Table 92. Akmpath Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Akmpath Recent Developments
Table 94. Raw Materials Key Suppliers
Table 95. Distributors List
Table 96. Market Trends and Market Evolution
Table 97. Market Drivers and Opportunities
Table 98. Market Challenges, Risks, and Restraints
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Third-party Pathology Diagnosis Center Product Picture
Figure 2. Global Third-party Pathology Diagnosis Center Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Third-Party Medical Testing Laboratory Product Picture
Figure 4. Independent Third-Party Pathology Diagnosis Center Product Picture
Figure 5. Global Third-party Pathology Diagnosis Center Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Third-party Pathology Diagnosis Center Report Years Considered
Figure 10. Global Third-party Pathology Diagnosis Center Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 12. Global Third-party Pathology Diagnosis Center Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Third-party Pathology Diagnosis Center Revenue Market Share by Region (2020-2031)
Figure 14. Global Third-party Pathology Diagnosis Center Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Third-Party Medical Testing Laboratory Revenue Market Share by Player in 2024
Figure 17. Independent Third-Party Pathology Diagnosis Center Revenue Market Share by Player in 2024
Figure 18. Global Third-party Pathology Diagnosis Center Revenue Market Share by Type (2020-2031)
Figure 19. Global Third-party Pathology Diagnosis Center Revenue Market Share by Application (2020-2031)
Figure 20. North America Third-party Pathology Diagnosis Center Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Third-party Pathology Diagnosis Center Revenue (US$ Million) in 2024
Figure 22. North America Third-party Pathology Diagnosis Center Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Third-party Pathology Diagnosis Center Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Third-party Pathology Diagnosis Center Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Third-party Pathology Diagnosis Center Revenue (US$ Million) in 2024
Figure 29. Europe Third-party Pathology Diagnosis Center Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Third-party Pathology Diagnosis Center Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 32. France Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Third-party Pathology Diagnosis Center Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Third-party Pathology Diagnosis Center Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Third-party Pathology Diagnosis Center Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Third-party Pathology Diagnosis Center Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 44. India Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Third-party Pathology Diagnosis Center Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Third-party Pathology Diagnosis Center Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Third-party Pathology Diagnosis Center Revenue (US$ Million) in 2024
Figure 52. Central and South America Third-party Pathology Diagnosis Center Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Third-party Pathology Diagnosis Center Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Third-party Pathology Diagnosis Center Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Third-party Pathology Diagnosis Center Revenue (US$ Million) in 2024
Figure 58. South America Third-party Pathology Diagnosis Center Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Third-party Pathology Diagnosis Center Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Third-party Pathology Diagnosis Center Revenue (2020-2025) & (US$ Million)
Figure 64. Third-party Pathology Diagnosis Center Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
